{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:20:01Z","timestamp":1772580001557,"version":"3.50.1"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"S8","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["19-15-00419"],"award-info":[{"award-number":["19-15-00419"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Vagal paragangliomas (VPGLs) belong to a group of rare head and neck neuroendocrine tumors. VPGLs arise from the vagus nerve and are less common than carotid paragangliomas. Both diagnostics and therapy of the tumors raise significant challenges. Besides, the genetic and molecular mechanisms behind VPGL pathogenesis are poorly understood.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The collection of VPGLs obtained from 8 patients of Russian population was used in the study. Exome library preparation and high-throughput sequencing of VPGLs were performed using an Illumina technology.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Based on exome analysis, we identified pathogenic\/likely pathogenic variants of the <jats:italic>SDHx<\/jats:italic> genes, frequently mutated in paragangliomas\/pheochromocytomas. <jats:italic>SDHB<\/jats:italic> variants were found in three patients, whereas <jats:italic>SDHD<\/jats:italic> was mutated in two cases. Moreover, likely pathogenic missense variants were also detected in <jats:italic>SDHAF3<\/jats:italic> and <jats:italic>SDHAF4<\/jats:italic> genes encoding for assembly factors for the succinate dehydrogenase (SDH) complex. In a patient, we found a novel variant of the <jats:italic>IDH2<\/jats:italic> gene that was predicted as pathogenic by a series of algorithms used (such as SIFT, PolyPhen2, FATHMM, MutationTaster, and LRT). Additionally, pathogenic\/likely pathogenic variants were determined for several genes, including novel genes and some genes previously reported as associated with different types of tumors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Results indicate a high heterogeneity among VPGLs, however, it seems that driver events in most cases are associated with mutations in the <jats:italic>SDHx<\/jats:italic> genes and SDH assembly factor-coding genes that lead to disruptions in the SDH complex.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12920-020-00763-4","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T06:03:52Z","timestamp":1600409032000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Mutation profiling in eight cases of vagal paragangliomas"],"prefix":"10.1186","volume":"13","author":[{"given":"Anna V.","family":"Kudryavtseva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitry V.","family":"Kalinin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladislav S.","family":"Pavlov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria V.","family":"Savvateeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria S.","family":"Fedorova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena A.","family":"Pudova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasiya A.","family":"Kobelyatskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander L.","family":"Golovyuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zulfiya G.","family":"Guvatova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George S.","family":"Razmakhaev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana B.","family":"Demidova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey A.","family":"Simanovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena N.","family":"Slavnova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrey \u0410.","family":"Poloznikov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrey P.","family":"Polyakov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nataliya V.","family":"Melnikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey A.","family":"Dmitriev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George S.","family":"Krasnov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4421-4364","authenticated-orcid":false,"given":"Anastasiya V.","family":"Snezhkina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,18]]},"reference":[{"issue":"1","key":"763_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1365-2273.2007.01378.x","volume":"32","author":"TP Martin","year":"2007","unstructured":"Martin TP, Irving RM, Maher ER. The genetics of paragangliomas: a review. Clin Otolaryngol. 2007;32(1):7\u201311.","journal-title":"Clin Otolaryngol"},{"issue":"3","key":"763_CR2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0361-9230(97)00020-8","volume":"43","author":"LE Goehler","year":"1997","unstructured":"Goehler LE, Relton JK, Dripps D, Kiechle R, Tartaglia N, Maier SF, Watkins LR. Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication. Brain Res Bull. 1997;43(3):357\u201364.","journal-title":"Brain Res Bull"},{"issue":"4","key":"763_CR3","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/BF00218147","volume":"169","author":"M Morgan","year":"1976","unstructured":"Morgan M, Pack RJ, Howe A. Structure of cells and nerve endings in abdominal vagal paraganglia of the rat. Cell Tissue Res. 1976;169(4):467\u201384.","journal-title":"Cell Tissue Res"},{"issue":"1 Pt 1","key":"763_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/000348948909800105","volume":"98","author":"HF Biller","year":"1989","unstructured":"Biller HF, Lawson W, Som P, Rosenfeld R. Glomus vagale tumors. Ann Otol Rhinol Laryngol. 1989;98(1 Pt 1):21\u20136.","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"Suppl 1","key":"763_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.6061\/clinics\/2012(Sup01)05","volume":"67","author":"C Offergeld","year":"2012","unstructured":"Offergeld C, Brase C, Yaremchuk S, Mader I, Rischke HC, Glasker S, Schmid KW, Wiech T, Preuss SF, Suarez C, et al. Head and neck paragangliomas: clinical and molecular genetic classification. Clinics. 2012;67(Suppl 1):19\u201328.","journal-title":"Clinics"},{"key":"763_CR6","unstructured":"El-Naggar AK, Chan JKC, Rubin Grandis J, Takata T, Slootweg PJ. WHO classification of head and neck tumours. Lyon: International Agency for Research on Cancer; 2017."},{"issue":"2","key":"763_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.5758\/vsi.2019.35.2.105","volume":"35","author":"T Kotsis","year":"2019","unstructured":"Kotsis T, Christoforou P. Vagal Paraganglioma: surgical removal with superior laryngeal nerve preservation. Vasc Specialist Int. 2019;35(2):105\u201310.","journal-title":"Vasc Specialist Int"},{"issue":"2","key":"763_CR8","doi-asserted-by":"publisher","DOI":"10.4081\/rt.2010.e21","volume":"2","author":"T Kataria","year":"2010","unstructured":"Kataria T, Bisht SS, Mitra S, Abhishek A, Potharaju S, Chakarvarty D. Synchronous malignant vagal paraganglioma with contralateral carotid body paraganglioma treated by radiation therapy. Rare Tumors. 2010;2(2):e21.","journal-title":"Rare Tumors"},{"issue":"2","key":"763_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s12105-015-0621-5","volume":"10","author":"ER Hamersley","year":"2016","unstructured":"Hamersley ER, Barrows A, Perez A, Schroeder A, Castle JT. Malignant Vagal Paraganglioma. Head Neck Pathol. 2016;10(2):201\u20135.","journal-title":"Head Neck Pathol"},{"issue":"9","key":"763_CR10","doi-asserted-by":"publisher","first-page":"R371","DOI":"10.1530\/ERC-16-0241","volume":"23","author":"A Varoquaux","year":"2016","unstructured":"Varoquaux A, Kebebew E, Sebag F, Wolf K, Henry JF, Pacak K, Taieb D. Endocrine tumors associated with the vagus nerve. Endocr Relat Cancer. 2016;23(9):R371\u20139.","journal-title":"Endocr Relat Cancer"},{"key":"763_CR11","first-page":"Doc03","volume":"10","author":"CC Boedeker","year":"2011","unstructured":"Boedeker CC. Paragangliomas and paraganglioma syndromes. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2011;10:Doc03.","journal-title":"GMS Curr Top Otorhinolaryngol Head Neck Surg"},{"issue":"5","key":"763_CR12","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/hed.21790","volume":"34","author":"K Papaspyrou","year":"2012","unstructured":"Papaspyrou K, Mewes T, Rossmann H, Fottner C, Schneider-Raetzke B, Bartsch O, Schreckenberger M, Lackner KJ, Amedee RG, Mann WJ. Head and neck paragangliomas: report of 175 patients (1989-2010). Head Neck. 2012;34(5):632\u20137.","journal-title":"Head Neck"},{"issue":"3","key":"763_CR13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1136\/jmg.39.3.178","volume":"39","author":"BE Baysal","year":"2002","unstructured":"Baysal BE, Willett-Brozick JE, Lawrence EC, Drovdlic CM, Savul SA, McLeod DR, Yee HA, Brackmann DE, Slattery WH 3rd, Myers EN, et al. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas. J Med Genet. 2002;39(3):178\u201383.","journal-title":"J Med Genet"},{"issue":"8","key":"763_CR14","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.1158\/0008-5472.CAN-08-4057","volume":"69","author":"HP Neumann","year":"2009","unstructured":"Neumann HP, Erlic Z, Boedeker CC, Rybicki LA, Robledo M, Hermsen M, Schiavi F, Falcioni M, Kwok P, Bauters C, et al. Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out. Cancer Res. 2009;69(8):3650\u20136.","journal-title":"Cancer Res"},{"issue":"5","key":"763_CR15","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.bbabio.2012.12.005","volume":"1827","author":"BE Baysal","year":"2013","unstructured":"Baysal BE. Mitochondrial complex II and genomic imprinting in inheritance of paraganglioma tumors. Biochim Biophys Acta. 2013;1827(5):573\u20137.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"763_CR16","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S1470-2045(10)70007-3","volume":"11","author":"JP Bayley","year":"2010","unstructured":"Bayley JP, Kunst HP, Cascon A, Sampietro ML, Gaal J, Korpershoek E, Hinojar-Gutierrez A, Timmers HJ, Hoefsloot LH, Hermsen MA, et al. SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. Lancet Oncol. 2010;11(4):366\u201372.","journal-title":"Lancet Oncol"},{"issue":"5944","key":"763_CR17","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1126\/science.1175689","volume":"325","author":"HX Hao","year":"2009","unstructured":"Hao HX, Khalimonchuk O, Schraders M, Dephoure N, Bayley JP, Kunst H, Devilee P, Cremers CW, Schiffman JD, Bentz BG, et al. SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science. 2009;325(5944):1139\u201342.","journal-title":"Science"},{"issue":"2","key":"763_CR18","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/ng1095-144","volume":"11","author":"T Bourgeron","year":"1995","unstructured":"Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Bourgeois M, Viegas-Pequignot E, Munnich A, Rotig A. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet. 1995;11(2):144\u20139.","journal-title":"Nat Genet"},{"issue":"9","key":"763_CR19","doi-asserted-by":"publisher","first-page":"E1472","DOI":"10.1210\/jc.2011-1043","volume":"96","author":"E Korpershoek","year":"2011","unstructured":"Korpershoek E, Favier J, Gaal J, Burnichon N, van Gessel B, Oudijk L, Badoual C, Gadessaud N, Venisse A, Bayley JP, et al. SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas. J Clin Endocrinol Metab. 2011;96(9):E1472\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"763_CR20","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1001\/jamaoncol.2017.0223","volume":"3","author":"B Bausch","year":"2017","unstructured":"Bausch B, Schiavi F, Ni Y, Welander J, Patocs A, Ngeow J, Wellner U, Malinoc A, Taschin E, Barbon G, et al. Clinical characterization of the Pheochromocytoma and Paraganglioma susceptibility genes SDHA, TMEM127, MAX, and SDHAF2 for gene-informed prevention. JAMA Oncol. 2017;3(9):1204\u201312.","journal-title":"JAMA Oncol"},{"issue":"Suppl 1","key":"763_CR21","first-page":"17","volume":"11","author":"AV Snezhkina","year":"2018","unstructured":"Snezhkina AV, Lukyanova EN, Kalinin DV, Pokrovsky AV, Dmitriev AA, Koroban NV, Pudova EA, Fedorova MS, Volchenko NN, Stepanov OA, et al. Exome analysis of carotid body tumor. BMC Med Genet. 2018;11(Suppl 1):17.","journal-title":"BMC Med Genet"},{"issue":"6","key":"763_CR22","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/hed.23436","volume":"36","author":"CC Boedeker","year":"2014","unstructured":"Boedeker CC, Hensen EF, Neumann HP, Maier W, van Nederveen FH, Suarez C, Kunst HP, Rodrigo JP, Takes RP, Pellitteri PK, et al. Genetics of hereditary head and neck paragangliomas. Head Neck. 2014;36(6):907\u201316.","journal-title":"Head Neck"},{"issue":"15","key":"763_CR23","doi-asserted-by":"publisher","first-page":"25756","DOI":"10.18632\/oncotarget.15201","volume":"8","author":"SO Zhikrivetskaya","year":"2017","unstructured":"Zhikrivetskaya SO, Snezhkina AV, Zaretsky AR, Alekseev BY, Pokrovsky AV, Golovyuk AL, Melnikova NV, Stepanov OA, Kalinin DV, Moskalev AA, et al. Molecular markers of paragangliomas\/pheochromocytomas. Oncotarget. 2017;8(15):25756\u201382.","journal-title":"Oncotarget"},{"issue":"8","key":"763_CR24","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1136\/jmedgenet-2018-105714","volume":"56","author":"L Ben Aim","year":"2019","unstructured":"Ben Aim L, Pigny P, Castro-Vega LJ, Buffet A, Amar L, Bertherat J, Drui D, Guilhem I, Baudin E, Lussey-Lepoutre C, et al. Targeted next-generation sequencing detects rare genetic events in pheochromocytoma and paraganglioma. J Med Genet. 2019;56(8):513\u201320.","journal-title":"J Med Genet"},{"issue":"Suppl 2","key":"763_CR25","first-page":"39","volume":"12","author":"AV Kudryavtseva","year":"2019","unstructured":"Kudryavtseva AV, Lukyanova EN, Kalinin DV, Zaretsky AR, Pokrovsky AV, Golovyuk AL, Fedorova MS, Pudova EA, Kharitonov SL, Pavlov VS, et al. Mutational load in carotid body tumor. BMC Med Genet. 2019;12(Suppl 2):39.","journal-title":"BMC Med Genet"},{"issue":"15","key":"763_CR26","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114\u201320.","journal-title":"Bioinformatics"},{"issue":"5","key":"763_CR27","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","volume":"26","author":"H Li","year":"2010","unstructured":"Li H, Durbin R. Fast and accurate long-read alignment with burrows-wheeler transform. Bioinformatics. 2010;26(5):589\u201395.","journal-title":"Bioinformatics"},{"issue":"16","key":"763_CR28","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R, Genome project data processing S. The sequence alignment\/map format and SAMtools. Bioinformatics. 2009;25(16):2078\u20139.","journal-title":"Bioinformatics"},{"issue":"9","key":"763_CR29","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297\u2013303.","journal-title":"Genome Res"},{"issue":"16","key":"763_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164.","journal-title":"Nucleic Acids Res"},{"key":"763_CR31","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1196\/annals.1353.032","volume":"1073","author":"ZP Zeng","year":"2006","unstructured":"Zeng ZP, Liu GQ, Li HZ, Fan XR, Liu DM, Tong AL, Zheng X, Liu C. The effects of urotensin-II on proliferation of pheochromocytoma cells and mRNA expression of urotensin-II and its receptor in pheochromocytoma tissues. Ann N Y Acad Sci. 2006;1073:284\u20139.","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"763_CR32","first-page":"457","volume":"27","author":"GQ Liu","year":"2005","unstructured":"Liu GQ, Zeng ZP, Li HZ, Fan XR, Liu DM, Tong AL, Zheng X, Liu C. Expression of urotensin II and G-protein coupled receptor 14 mRNA in human pheochromocytoma tissues. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005;27(4):457\u201360.","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"issue":"4","key":"763_CR33","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1134\/S0026893319040137","volume":"53","author":"AV Snezhkina","year":"2019","unstructured":"Snezhkina AV, Lukyanova EN, Fedorova MS, Kalinin DV, Melnikova NV, Stepanov OA, Kiseleva MV, Kaprin AD, Pudova EA, Kudryavtseva AV. Novel genes associated with the development of carotid Paragangliomas. Mol Biol. 2019;53(4):613\u201326.","journal-title":"Mol Biol"},{"issue":"4","key":"763_CR34","doi-asserted-by":"publisher","first-page":"R71","DOI":"10.1186\/bcr2136","volume":"10","author":"Y Radestock","year":"2008","unstructured":"Radestock Y, Hoang-Vu C, Hombach-Klonisch S. Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells. Breast Cancer Res. 2008;10(4):R71.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"763_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10585-013-9609-2","volume":"31","author":"C Binder","year":"2014","unstructured":"Binder C, Chuang E, Habla C, Bleckmann A, Schulz M, Bathgate R, Einspanier A. Relaxins enhance growth of spontaneous murine breast cancers as well as metastatic colonization of the brain. Clin Exp Metastasis. 2014;31(1):57\u201365.","journal-title":"Clin Exp Metastasis"},{"issue":"4","key":"763_CR36","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1158\/1541-7786.MCR-09-0307","volume":"8","author":"Y Radestock","year":"2010","unstructured":"Radestock Y, Willing C, Kehlen A, Hoang-Vu C, Hombach-Klonisch S. Relaxin enhances S100A4 and promotes growth of human thyroid carcinoma cell xenografts. Mol Cancer Res. 2010;8(4):494\u2013506.","journal-title":"Mol Cancer Res"},{"key":"763_CR37","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1749-6632.2008.03793.x","volume":"1160","author":"S Feng","year":"2009","unstructured":"Feng S, Agoulnik IU, Li Z, Han HD, Lopez-Berestein G, Sood A, Ittmann MM, Agoulnik AI. Relaxin\/RXFP1 signaling in prostate cancer progression. Ann N Y Acad Sci. 2009;1160:379\u201380.","journal-title":"Ann N Y Acad Sci"},{"key":"763_CR38","doi-asserted-by":"crossref","unstructured":"Fue M, Miki Y, Takagi K, Hashimoto C, Yaegashi N, Suzuki T, Ito K. Relaxin 2\/RXFP1 Signaling Induces Cell Invasion via the beta-Catenin Pathway in Endometrial Cancer. Int J Mol Sci. 2018;19(8):2438.","DOI":"10.3390\/ijms19082438"},{"issue":"4","key":"763_CR39","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/path.4257","volume":"231","author":"A Glogowska","year":"2013","unstructured":"Glogowska A, Kunanuvat U, Stetefeld J, Patel TR, Thanasupawat T, Krcek J, Weber E, Wong GW, Del Bigio MR, Hoang-Vu C, et al. C1q-tumour necrosis factor-related protein 8 (CTRP8) is a novel interaction partner of relaxin receptor RXFP1 in human brain cancer cells. J Pathol. 2013;231(4):466\u201379.","journal-title":"J Pathol"},{"key":"763_CR40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.mce.2019.02.001","volume":"487","author":"T Thanasupawat","year":"2019","unstructured":"Thanasupawat T, Glogowska A, Nivedita-Krishnan S, Wilson B, Klonisch T, Hombach-Klonisch S. Emerging roles for the relaxin\/RXFP1 system in cancer therapy. Mol Cell Endocrinol. 2019;487:85\u201393.","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"763_CR41","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1158\/0008-5472.CAN-12-1472","volume":"73","author":"DR Croucher","year":"2013","unstructured":"Croucher DR, Hochgrafe F, Zhang L, Liu L, Lyons RJ, Rickwood D, Tactacan CM, Browne BC, Ali N, Chan H, et al. Involvement of Lyn and the atypical kinase SgK269\/PEAK1 in a basal breast cancer signaling pathway. Cancer Res. 2013;73(6):1969\u201380.","journal-title":"Cancer Res"},{"issue":"22","key":"763_CR42","doi-asserted-by":"publisher","first-page":"6671","DOI":"10.1158\/0008-5472.CAN-14-1031","volume":"74","author":"K Fujimura","year":"2014","unstructured":"Fujimura K, Wright T, Strnadel J, Kaushal S, Metildi C, Lowy AM, Bouvet M, Kelber JA, Klemke RL. A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer. Cancer Res. 2014;74(22):6671\u201381.","journal-title":"Cancer Res"},{"issue":"12","key":"763_CR43","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.prp.2014.09.013","volume":"210","author":"Q Guo","year":"2014","unstructured":"Guo Q, Qin W, Li B, Yang H, Guan J, Liu Z, Li S. Analysis of a cytoskeleton-associated kinase PEAK1 and E-cadherin in gastric cancer. Pathol Res Pract. 2014;210(12):793\u20138.","journal-title":"Pathol Res Pract"},{"issue":"3","key":"763_CR44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41419-018-0320-8","volume":"9","author":"L Huang","year":"2018","unstructured":"Huang L, Wen C, Yang X, Lou Q, Wang X, Che J, Chen J, Yang Z, Wu X, Huang M, et al. PEAK1, acting as a tumor promoter in colorectal cancer, is regulated by the EGFR\/KRas signaling axis and miR-181d. Cell Death Dis. 2018;9(3):271.","journal-title":"Cell Death Dis"},{"issue":"8","key":"763_CR45","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41419-018-0817-1","volume":"9","author":"C Ding","year":"2018","unstructured":"Ding C, Tang W, Fan X, Wang X, Wu H, Xu H, Xu W, Gao W, Wu G. Overexpression of PEAK1 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer through modulating ERK1\/2 and JAK2 signaling. Cell Death Dis. 2018;9(8):802.","journal-title":"Cell Death Dis"},{"issue":"23","key":"763_CR46","doi-asserted-by":"publisher","first-page":"10520","DOI":"10.1073\/pnas.1001896107","volume":"107","author":"R Marlow","year":"2010","unstructured":"Marlow R, Binnewies M, Sorensen LK, Monica SD, Strickland P, Forsberg EC, Li DY, Hinck L. Vascular Robo4 restricts proangiogenic VEGF signaling in breast. Proc Natl Acad Sci U S A. 2010;107(23):10520\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"763_CR47","doi-asserted-by":"crossref","first-page":"175883591985523","DOI":"10.1177\/1758835919855238","volume":"11","author":"Z Jiang","year":"2019","unstructured":"Jiang Z, Liang G, Xiao Y, Qin T, Chen X, Wu E, Ma Q, Wang Z. Targeting the SLIT\/ROBO pathway in tumor progression: molecular mechanisms and therapeutic perspectives. Ther Adv Med Oncol. 2019;11:1758835919855238.","journal-title":"Ther Adv Med Oncol"},{"issue":"29","key":"763_CR48","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.1038\/sj.onc.1206687","volume":"22","author":"A Dallol","year":"2003","unstructured":"Dallol A, Krex D, Hesson L, Eng C, Maher ER, Latif F. Frequent epigenetic inactivation of the SLIT2 gene in gliomas. Oncogene. 2003;22(29):4611\u20136.","journal-title":"Oncogene"},{"issue":"7","key":"763_CR49","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1002\/j.1460-2075.1992.tb05317.x","volume":"11","author":"B Lichte","year":"1992","unstructured":"Lichte B, Veh RW, Meyer HE, Kilimann MW. Amphiphysin, a novel protein associated with synaptic vesicles. EMBO J. 1992;11(7):2521\u201330.","journal-title":"EMBO J"},{"issue":"1","key":"763_CR50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/9004","volume":"1","author":"K Takei","year":"1999","unstructured":"Takei K, Slepnev VI, Haucke V, De Camilli P. Functional partnership between amphiphysin and dynamin in clathrin-mediated endocytosis. Nat Cell Biol. 1999;1(1):33\u20139.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"763_CR51","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/ana.20529","volume":"58","author":"SJ Pittock","year":"2005","unstructured":"Pittock SJ, Lucchinetti CF, Parisi JE, Benarroch EE, Mokri B, Stephan CL, Kim KK, Kilimann MW, Lennon VA. Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol. 2005;58(1):96\u2013107.","journal-title":"Ann Neurol"},{"issue":"12","key":"763_CR52","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.7150\/jca.25428","volume":"9","author":"Y Chen","year":"2018","unstructured":"Chen Y, Liu J, Li L, Xia H, Lin Z, Zhong T. AMPH-1 is critical for breast cancer progression. J Cancer. 2018;9(12):2175\u201382.","journal-title":"J Cancer"},{"issue":"1","key":"763_CR53","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1186\/s12885-017-3486-z","volume":"17","author":"T Dwight","year":"2017","unstructured":"Dwight T, Na U, Kim E, Zhu Y, Richardson AL, Robinson BG, Tucker KM, Gill AJ, Benn DE, Clifton-Bligh RJ, et al. Analysis of SDHAF3 in familial and sporadic pheochromocytoma and paraganglioma. BMC Cancer. 2017;17(1):497.","journal-title":"BMC Cancer"},{"issue":"1","key":"763_CR54","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3892\/ol.2016.4644","volume":"12","author":"WL Sun","year":"2016","unstructured":"Sun WL. Ambra1 in autophagy and apoptosis: implications for cell survival and chemotherapy resistance. Oncol Lett. 2016;12(1):367\u201374.","journal-title":"Oncol Lett"},{"issue":"12","key":"763_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083943","volume":"8","author":"Y Yu","year":"2013","unstructured":"Yu Y, Walia V, Elble RC. Loss of CLCA4 promotes epithelial-to-mesenchymal transition in breast cancer cells. PLoS One. 2013;8(12):e83943.","journal-title":"PLoS One"},{"key":"763_CR56","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.12659\/MSM.914195","volume":"25","author":"H Chen","year":"2019","unstructured":"Chen H, Liu Y, Jiang CJ, Chen YM, Li H, Liu QA. Calcium-activated Chloride Channel A4 (CLCA4) plays inhibitory roles in invasion and migration through suppressing epithelial-Mesenchymal transition via PI3K\/AKT signaling in colorectal Cancer. Med Sci Monit. 2019;25:4176\u201385.","journal-title":"Med Sci Monit"},{"issue":"7","key":"763_CR57","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1080\/14737159.2019.1631799","volume":"19","author":"M Carausu","year":"2019","unstructured":"Carausu M, Bidard FC, Callens C, Melaabi S, Jeannot E, Pierga JY, Cabel L. ESR1 mutations: a new biomarker in breast cancer. Expert Rev Mol Diagn. 2019;19(7):599\u2013611.","journal-title":"Expert Rev Mol Diagn"},{"key":"763_CR58","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.12659\/MSM.913746","volume":"25","author":"Y Tan","year":"2019","unstructured":"Tan Y, Zhang T, Zhou L, Liu S, Liang C. MiR-34b-3p represses the multidrug-Chemoresistance of bladder Cancer cells by regulating the CCND2 and P2RY1 genes. Med Sci Monit. 2019;25:1323\u201335.","journal-title":"Med Sci Monit"},{"issue":"7","key":"763_CR59","doi-asserted-by":"publisher","first-page":"5310","DOI":"10.18632\/oncotarget.2776","volume":"6","author":"G Chiappetta","year":"2015","unstructured":"Chiappetta G, Valentino T, Vitiello M, Pasquinelli R, Monaco M, Palma G, Sepe R, Luciano A, Pallante P, Palmieri D, et al. PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration. Oncotarget. 2015;6(7):5310\u201323.","journal-title":"Oncotarget"},{"issue":"1","key":"763_CR60","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/path.2323","volume":"215","author":"M Fedele","year":"2008","unstructured":"Fedele M, Franco R, Salvatore G, Paronetto MP, Barbagallo F, Pero R, Chiariotti L, Sette C, Tramontano D, Chieffi G, et al. PATZ1 gene has a critical role in the spermatogenesis and testicular tumours. J Pathol. 2008;215(1):39\u201347.","journal-title":"J Pathol"},{"key":"763_CR61","doi-asserted-by":"crossref","unstructured":"Bridge JA, Sumegi J, Druta M, Bui MM, Henderson-Jackson E, Linos K, Baker M, Walko CM, Millis S, Brohl AS. Clinical, pathological, and genomic features of EWSR1-PATZ1 fusion sarcoma. Modern Pathol. 2019;32(11):1593\u2013604.","DOI":"10.1038\/s41379-019-0301-1"},{"issue":"32","key":"763_CR62","doi-asserted-by":"publisher","first-page":"52255","DOI":"10.18632\/oncotarget.10427","volume":"7","author":"MY Ho","year":"2016","unstructured":"Ho MY, Liang CM, Liang SM. PATZ1 induces PP4R2 to form a negative feedback loop on IKK\/NF-kappaB signaling in lung cancer. Oncotarget. 2016;7(32):52255\u201369.","journal-title":"Oncotarget"},{"issue":"2","key":"763_CR63","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/gcc.20514","volume":"47","author":"YL Yang","year":"2008","unstructured":"Yang YL, Chu JY, Luo ML, Wu YP, Zhang Y, Feng YB, Shi ZZ, Xu X, Han YL, Cai Y, et al. Amplification of PRKCI, located in 3q26, is associated with lymph node metastasis in esophageal squamous cell carcinoma. Genes, Chromosomes Cancer. 2008;47(2):127\u201336.","journal-title":"Genes, Chromosomes Cancer"},{"issue":"2","key":"763_CR64","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4161\/cc.11.2.18898","volume":"11","author":"D Campa","year":"2012","unstructured":"Campa D, Canzian F, Kaaks R. Genetic variability in the PRKCI gene and prostate cancer risk. Cell Cycle. 2012;11(2):209.","journal-title":"Cell Cycle"},{"issue":"4","key":"763_CR65","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s12253-017-0297-0","volume":"24","author":"EJ Choi","year":"2018","unstructured":"Choi EJ, Lee JH, Kim MS, Song SY, Yoo NJ, Lee SH. Intratumoral heterogeneity of somatic mutations for NRIP1, DOK1, ULK1, ULK2, DLGAP3, PARD3 and PRKCI in Colon cancers. Pathol Oncol Res. 2018;24(4):827\u201332.","journal-title":"Pathol Oncol Res"},{"issue":"2","key":"763_CR66","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.18632\/oncotarget.13707","volume":"8","author":"H Guo","year":"2017","unstructured":"Guo H, Zhou S, Tan L, Wu X, Wu Z, Ran R. Clinicopathological significance of WIF1 hypermethylation in NSCLC, a meta-analysis and literature review. Oncotarget. 2017;8(2):2550\u20137.","journal-title":"Oncotarget"},{"issue":"1","key":"763_CR67","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/s41598-017-01763-8","volume":"7","author":"P Liu","year":"2017","unstructured":"Liu P, Shen JK, Hornicek FJ, Liu F, Duan Z. Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcoma. Sci Rep. 2017;7(1):1580.","journal-title":"Sci Rep"},{"issue":"10","key":"763_CR68","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1002\/jmv.24863","volume":"89","author":"Z Zhao","year":"2017","unstructured":"Zhao Z, Liu W, Liu J, Wang J, Luo B. The effect of EBV on WIF1, NLK, and APC gene methylation and expression in gastric carcinoma and nasopharyngeal cancer. J Med Virol. 2017;89(10):1844\u201351.","journal-title":"J Med Virol"},{"issue":"4","key":"763_CR69","doi-asserted-by":"publisher","first-page":"5378","DOI":"10.18632\/oncotarget.23870","volume":"9","author":"H Hu","year":"2018","unstructured":"Hu H, Li B, Zhou C, Ying X, Chen M, Huang T, Chen Y, Ji H, Pan R, Wang T, et al. Diagnostic value of WIF1 methylation for colorectal cancer: a meta-analysis. Oncotarget. 2018;9(4):5378\u201386.","journal-title":"Oncotarget"},{"issue":"3","key":"763_CR70","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1210\/jc.2006-2315","volume":"92","author":"HJ Timmers","year":"2007","unstructured":"Timmers HJ, Kozupa A, Eisenhofer G, Raygada M, Adams KT, Solis D, Lenders JW, Pacak K. Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas. J Clin Endocrinol Metab. 2007;92(3):779\u201386.","journal-title":"J Clin Endocrinol Metab"},{"key":"763_CR71","first-page":"502734","volume":"2014","author":"H Choat","year":"2014","unstructured":"Choat H, Derrevere K, Knight L, Brown W, Mack EH. SDHB-associated Paraganglioma in a pediatric patient and literature review on hereditary Pheochromocytoma-Paraganglioma syndromes. Case Rep Endocrinol. 2014;2014:502734.","journal-title":"Case Rep Endocrinol"},{"issue":"6","key":"763_CR72","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/j.juro.2012.08.030","volume":"188","author":"CJ Ricketts","year":"2012","unstructured":"Ricketts CJ, Shuch B, Vocke CD, Metwalli AR, Bratslavsky G, Middelton L, Yang Y, Wei MH, Pautler SE, Peterson J, et al. Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. J Urol. 2012;188(6):2063\u201371.","journal-title":"J Urol"},{"issue":"33","key":"763_CR73","doi-asserted-by":"publisher","first-page":"e812","DOI":"10.1200\/JCO.2011.36.2269","volume":"29","author":"TD Poeppel","year":"2011","unstructured":"Poeppel TD, Yuece A, Boy C, Metz KA, Kaminsky E, Neumann HP, Rosenbaum SJ, Mann K, Moeller LC. Novel SDHD gene mutation (H102R) in a patient with metastatic cervical paraganglioma effectively treated by peptide receptor radionuclide therapy. J Clin Oncol. 2011;29(33):e812\u20135.","journal-title":"J Clin Oncol"},{"issue":"5454","key":"763_CR74","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1126\/science.287.5454.848","volume":"287","author":"BE Baysal","year":"2000","unstructured":"Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, van der Mey A, Taschner PE, Rubinstein WS, Myers EN, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science. 2000;287(5454):848\u201351.","journal-title":"Science"},{"issue":"8","key":"763_CR75","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1210\/jc.2008-2504","volume":"94","author":"N Burnichon","year":"2009","unstructured":"Burnichon N, Rohmer V, Amar L, Herman P, Leboulleux S, Darrouzet V, Niccoli P, Gaillard D, Chabrier G, Chabolle F, et al. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. J Clin Endocrinol Metab. 2009;94(8):2817\u201327.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"763_CR76","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1530\/ERC-11-0369","volume":"19","author":"V Piccini","year":"2012","unstructured":"Piccini V, Rapizzi E, Bacca A, Di Trapani G, Pulli R, Giache V, Zampetti B, Lucci-Cordisco E, Canu L, Corsini E, et al. Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients. Endocr Relat Cancer. 2012;19(2):149\u201355.","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"763_CR77","first-page":"1770","volume":"40","author":"T Kinoshita","year":"2012","unstructured":"Kinoshita T, Nohata N, Watanabe-Takano H, Yoshino H, Hidaka H, Fujimura L, Fuse M, Yamasaki T, Enokida H, Nakagawa M, et al. Actin-related protein 2\/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma. Int J Oncol. 2012;40(6):1770\u20138.","journal-title":"Int J Oncol"},{"key":"763_CR78","doi-asserted-by":"publisher","first-page":"6340","DOI":"10.12659\/MSM.908944","volume":"24","author":"T Xiong","year":"2018","unstructured":"Xiong T, Luo Z. The expression of actin-related protein 2\/3 complex subunit 5 (ARPC5) expression in multiple myeloma and its prognostic significance. Med Sci Monit. 2018;24:6340\u20138.","journal-title":"Med Sci Monit"},{"issue":"13","key":"763_CR79","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1093\/nar\/gkl476","volume":"34","author":"KM Bhat","year":"2006","unstructured":"Bhat KM, Maddodi N, Shashikant C, Setaluri V. Transcriptional regulation of human MAP 2 gene in melanoma: role of neuronal bHLH factors and Notch1 signaling. Nucleic Acids Res. 2006;34(13):3819\u201332.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"763_CR80","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10735-018-9760-9","volume":"49","author":"R Yi","year":"2018","unstructured":"Yi R, Feng J, Yang S, Huang X, Liao Y, Hu Z, Luo M. miR-484\/MAP 2\/c-Myc-positive regulatory loop in glioma promotes tumor-initiating properties through ERK1\/2 signaling. J Mol Histol. 2018;49(2):209\u201318.","journal-title":"J Mol Histol"},{"issue":"2","key":"763_CR81","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.bbrc.2007.11.179","volume":"366","author":"SY Liu","year":"2008","unstructured":"Liu SY, Chen YT, Tseng MY, Hung CC, Chiang WF, Chen HR, Shieh TY, Chen CH, Jou YS, Chen JY. Involvement of microtubule-associated protein 2 (MAP 2) in oral cancer cell motility: a novel biological function of MAP 2 in non-neuronal cells. Biochem Biophys Res Commun. 2008;366(2):520\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"763_CR82","first-page":"6606","volume":"7","author":"S Zheng","year":"2014","unstructured":"Zheng S, Shi L, Zhang Y, He T. Expression of SNCG, MAP 2, SDF-1 and CXCR4 in gastric adenocarcinoma and their clinical significance. Int J Clin Exp Pathol. 2014;7(10):6606\u201315.","journal-title":"Int J Clin Exp Pathol"},{"issue":"11","key":"763_CR83","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nrc3612","volume":"13","author":"AT Shaw","year":"2013","unstructured":"Shaw AT, Hsu PP, Awad MM, Engelman JA. Tyrosine kinase gene rearrangements in epithelial malignancies. Nat Rev Cancer. 2013;13(11):772\u201387.","journal-title":"Nat Rev Cancer"},{"key":"763_CR84","first-page":"273423","volume":"2014","author":"D Graham","year":"2014","unstructured":"Graham D, Gooch M, Ye Z, Richer E, Chishti A, Reilly E, D'Orazio J. Pheochromocytoma in a twelve-year-old girl with SDHB-related hereditary Paraganglioma-Pheochromocytoma syndrome. Case Rep Genetics. 2014;2014:273423.","journal-title":"Case Rep Genetics"},{"issue":"1","key":"763_CR85","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s12020-009-9204-0","volume":"36","author":"M Naito","year":"2009","unstructured":"Naito M, Usui T, Tamanaha T, Kawashima ST, Iogawa H, Hagiwara H, Kimura T, Tagami T, Kurosawa M, Shimatsu A, et al. R27X nonsense mutation of the SDHB gene in a patient with sporadic malignant paraganglioma. Endocrine. 2009;36(1):10\u20135.","journal-title":"Endocrine"},{"issue":"1","key":"763_CR86","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1086\/381054","volume":"74","author":"S Vanharanta","year":"2004","unstructured":"Vanharanta S, Buchta M, McWhinney SR, Virta SK, Peczkowska M, Morrison CD, Lehtonen R, Januszewicz A, Jarvinen H, Juhola M, et al. Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. Am J Hum Genet. 2004;74(1):153\u20139.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"763_CR87","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3109\/03602532.2014.901348","volume":"46","author":"T Kunicka","year":"2014","unstructured":"Kunicka T, Soucek P. Importance of ABCC1 for cancer therapy and prognosis. Drug Metab Rev. 2014;46(3):325\u201342.","journal-title":"Drug Metab Rev"},{"key":"763_CR88","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cbi.2019.02.013","volume":"302","author":"SA Krupenko","year":"2019","unstructured":"Krupenko SA, Krupenko NI. Loss of ALDH1L1 folate enzyme confers a selective metabolic advantage for tumor progression. Chem Biol Interact. 2019;302:149\u201355.","journal-title":"Chem Biol Interact"},{"issue":"43","key":"763_CR89","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.1038\/sj.onc.1209875","volume":"25","author":"E Honrado","year":"2006","unstructured":"Honrado E, Osorio A, Palacios J, Benitez J. Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations. Oncogene. 2006;25(43):5837\u201345.","journal-title":"Oncogene"},{"issue":"35","key":"763_CR90","doi-asserted-by":"publisher","first-page":"58172","DOI":"10.18632\/oncotarget.17345","volume":"8","author":"R Jin","year":"2017","unstructured":"Jin R, Shen J, Zhang T, Liu Q, Liao C, Ma H, Li S, Yu Z. The highly expressed COL4A1 genes contributes to the proliferation and migration of the invasive ductal carcinomas. Oncotarget. 2017;8(35):58172\u201383.","journal-title":"Oncotarget"},{"issue":"2","key":"763_CR91","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41419-019-1351-5","volume":"10","author":"S Saini","year":"2019","unstructured":"Saini S, Sripada L, Tulla K, Kumar P, Yue F, Kunda N, Maker AV, Prabhakar BS. Loss of MADD expression inhibits cellular growth and metastasis in anaplastic thyroid cancer. Cell Death Dis. 2019;10(2):145.","journal-title":"Cell Death Dis"},{"issue":"11","key":"763_CR92","doi-asserted-by":"publisher","first-page":"11381","DOI":"10.1007\/s13277-014-2472-1","volume":"35","author":"Y Yongbin","year":"2014","unstructured":"Yongbin Y, Jinghua L, Zhanxue Z, Aimin Z, Youchao J, Yanhong S, Manjing J. TES was epigenetically silenced and suppressed the epithelial-mesenchymal transition in breast cancer. Tumour Biol. 2014;35(11):11381\u20139.","journal-title":"Tumour Biol"},{"key":"763_CR93","doi-asserted-by":"crossref","unstructured":"Yee NS. Role of TRPM7 in Cancer: Potential as Molecular Biomarker and Therapeutic Target. Pharmaceuticals. 2017;10(2):39.","DOI":"10.3390\/ph10020039"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-020-00763-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-020-00763-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-020-00763-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T23:21:05Z","timestamp":1631920865000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-020-00763-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":93,"journal-issue":{"issue":"S8","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["763"],"URL":"https:\/\/doi.org\/10.1186\/s12920-020-00763-4","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"23 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the ethics committee from the Vishnevsky Institute of Surgery and performed according to the Declaration of Helsinki (1964). All patients provided a written informed consent for their participation in the study. Written informed consent was obtained from all of the participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patients for publication of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"115"}}